Contrast Volume Reduction During PCI With the Use of a New Assisting Software Package

Stopped early

Conditions studied: Coronary Stenosis, Coronary Occlusion

In brief

The new software package is intended to assist the physician in imaging the coronaries during percutaneous coronary interventions. This study investigates the amount of contrast used during percutaneous coronary interventions with the aid of the new software package. The results of the study will be compared with control group data (before the new software package was installed or after it was removed) to define a possible contrast reduction.

Key facts

Study ID

NCT02927990

Run by

Philips Clinical & Medical Affairs Global

People needed

80

Starts

2017-12-15

Expected to finish

2019-06-30

Last updated by the study team

2024-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject undergoing a percutaneous coronary intervention.
• Subject 18 years of age or older, or of legal age to give informed consent per state or national law.

You may not qualify if…

• Subject undergoing an emergency treatment
• Primary angioplasty for acute ST segment elevation myocardial infarction.
• Subject with contrast allergies
• Subject with severe kidney disease (e-GFR < 40 by Modification of Diet in Renal Disease (MDRD)/Cockcroft Gault clearance formula and/or upon decision by investigator)
• Subject participates in a potentially confounding drug or device trial during the course of the study.
• Prisoners, people who cannot legally give consent, pregnant women and breastfeeding women.

Where it is running

• Columbia University Medical Center/NYPH — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.